相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis
Sara Lemoinne et al.
GUT (2020)
Systematic review: chronic viral hepatitis and metabolic derangement
Chia-Chi Wang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
HEPATOLOGY (2020)
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
Shiv K. Sarin et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population-based study
Yuan-Hung Kuo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Reza Fadaei et al.
SCIENTIFIC REPORTS (2018)
Improved Noninvasive Prediction of Liver Fibrosis by Liver Stiffness Measurement in Patients With Nonalcoholic Fatty Liver Disease Accounting for Controlled Attenuation Parameter Values
Salvatore Petta et al.
HEPATOLOGY (2017)
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
Thomas Karlas et al.
JOURNAL OF HEPATOLOGY (2017)
The correlation of controlled attenuation parameter results with ultrasound-identified steatosis in real-world clinical practice
Yi-Hao Yen et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2017)
Functional foods and dietary supplements for the management of dyslipidaemia
Paola M. Hunter et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2016)
Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile
Mohammad S. Siddiqui et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis
Vasiliy Ivanovich Reshetnyak
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target
Wen-Yue Liu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Getting closer to a point-of-care diagnostic assessment in patients with chronic liver disease: Controlled attenuation parameter for steatosis
Annalisa Berzigotti
JOURNAL OF HEPATOLOGY (2014)
Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population
Young Eun Chon et al.
LIVER INTERNATIONAL (2014)
Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases
Keiichi Masaki et al.
HEPATOLOGY RESEARCH (2013)
Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: Does etiology affect performance?
Manoj Kumar et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Hepatitis B virus infection and fatty liver in the general population
Vincent Wai-Sun Wong et al.
JOURNAL OF HEPATOLOGY (2012)
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography
Robert P. Myers et al.
LIVER INTERNATIONAL (2012)
Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease
Hemant Chatrath et al.
SEMINARS IN LIVER DISEASE (2012)
Assessment of metabolic syndrome in patients with primary biliary cirrhosis
Tamara Alempijevic et al.
WIENER KLINISCHE WOCHENSCHRIFT (2012)
Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity
Piia Simonen et al.
JOURNAL OF HEPATOLOGY (2011)
Impact of HDL on adipose tissue metabolism and adiponectin expression
Sophie Van Linthout et al.
ATHEROSCLEROSIS (2010)
Plasma adiponectin levels in primary biliary cirrhosis: A novel perspective for link between hypercholesterolemia and protection against atherosclerosis
Annarosa Floreani et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Hepatitis C and steatosis
Einar Bjornsson et al.
ARCHIVES OF MEDICAL RESEARCH (2007)
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Takashi Kadowaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Serum lipid pattern in chronic hepatitis C: histological and virological correlations
D Siagris et al.
JOURNAL OF VIRAL HEPATITIS (2006)
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
AM Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis
M Longo et al.
GUT (2002)
分享论文
